Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?

Savani, Bipin N; Pohlmann, Paula R; Jagasia, Madan; Chinratanalab, Wichai; Kassim, Adetola; Engelhardt, Brian; Greer, John; Schuening, Friedrich; Goodman, Stacey (2009). Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD? Blood, 113(24), pp. 6263-4. Washington, D.C.: American Society of Hematology 10.1182/blood-2009-04-213892

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Further Contribution)

ISSN:

0006-4971

Publisher:

American Society of Hematology

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:13

Last Modified:

04 May 2014 23:23

Publisher DOI:

10.1182/blood-2009-04-213892

PubMed ID:

19520823

Web of Science ID:

000267147100037

URI:

https://boris.unibe.ch/id/eprint/32141 (FactScience: 197068)

Actions (login required)

Edit item Edit item
Provide Feedback